MooreMedical Supporting Health & Care...MooreBrand Blood Glucose Monitor for Self-Testing…
Recall Z-0909-2014, part of FDA recall event 67152. See Nipro Diagnostics's company page.
Nipro Diagnostics, Inc. started this Class II device recall on Oct 2, 2013 (voluntary: firm initiated); FDA lists it as terminated, terminated Jan 28, 2016.
- Classification: Class II
- Started: Oct 2, 2013
- Status: Terminated
- Products in this event: 2
Manufactured with an incorrect factory set unit of measure.
- Product
- MooreMedical Supporting Health & Care...MooreBrand Blood Glucose Monitor for Self-Testing & Multi-Patient Use TRUEbalance. Manufactured by: NIPRO DIAGNOSTICS, Fort Lauderdale, FL 33309 U.S.A. Is intended for the quantitative determination of glucose in human whole blood taken from finger or forearm.
- Quantity
- 501
- Lots and codes
- Finished Good: KK0468; Lot Numbers: KL01079, KM0337TI, KN1834TI, KN1973TI, KN2074TI, KN 2089TI, KN2090TI, KN2102TI, KP0047TI, KP0076TI, KP0128TI, KP0925TI.
- Distribution
- Worldwide Distribution - USA (nationwide, HI and Puerto Rico and Internationally to Canada, European Union, Jamaica, Suriname, Trinidad and Tobago, Kazakhastan, Russian, Turkey, Australia, Bangladesh, Pakistan, Cambodia, Laos, Myanmar, Thailand, Vietnam, and India.
- Recalling firm
- Nipro Diagnostics, Inc., Ft Lauderdale, FL, United States
- How the firm notified
- Letter
- FDA classified
- Feb 3, 2014
- MooreMedical Supporting Health & Care...MooreBrand Blood Glucose Monitor for Self-Testing & Multi-Patient Use…Z-0910-2014 · Class II · Oct 2, 2013 · Terminated
Newest first, one product per recall event; search them all
- Duane Reade TRUEtrack monitor kit, UPC# 6 39194 01679 7 Part # A4006-81 The TRUEtrack Blood Glucose System is…Z-1140-2013 · Class II · Feb 25, 2013 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports